Advertisement

Topics

Not Quite FDARA Add-Ons: Right-To-Try, Patient Experience, Opioid Measures Also Clear US Senate

13:00 EDT 3 Aug 2017 | SCRIP

Senate passage of the FDA user fee package without amendments was enabled by unanimous consent votes on controversial right-to-try legislation...

      

Related Stories

 

Original Article: Not Quite FDARA Add-Ons: Right-To-Try, Patient Experience, Opioid Measures Also Clear US Senate

NEXT ARTICLE

More From BioPortfolio on "Not Quite FDARA Add-Ons: Right-To-Try, Patient Experience, Opioid Measures Also Clear US Senate"

Quick Search
Advertisement